140 related articles for article (PubMed ID: 16185164)
21. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.
Meurs H; Hamer MA; Pethe S; Vadon-Le Goff S; Boucher JL; Zaagsma J
Br J Pharmacol; 2000 Aug; 130(8):1793-8. PubMed ID: 10952667
[TBL] [Abstract][Full Text] [Related]
22. The arginine-arginase balance in asthma and lung inflammation.
Zimmermann N; Rothenberg ME
Eur J Pharmacol; 2006 Mar; 533(1-3):253-62. PubMed ID: 16458291
[TBL] [Abstract][Full Text] [Related]
23. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma.
North ML; Khanna N; Marsden PA; Grasemann H; Scott JA
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L911-20. PubMed ID: 19286931
[TBL] [Abstract][Full Text] [Related]
24. In hepatocytes the regulation of NOS-2 activity at physiological L-arginine levels suggests a close link to the urea cycle.
Lerzynski G; Suschek CV; Kolb-Bachofen V
Nitric Oxide; 2006 Jun; 14(4):300-8. PubMed ID: 16410053
[TBL] [Abstract][Full Text] [Related]
25. Increased ornithine-derived polyamines cause airway hyperresponsiveness in a mouse model of asthma.
North ML; Grasemann H; Khanna N; Inman MD; Gauvreau GM; Scott JA
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):694-702. PubMed ID: 23470627
[TBL] [Abstract][Full Text] [Related]
26. Classical and slow-binding inhibitors of human type II arginase.
Colleluori DM; Ash DE
Biochemistry; 2001 Aug; 40(31):9356-62. PubMed ID: 11478904
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological Screening Identifies SHK242 and SHK277 as Novel Arginase Inhibitors with Efficacy against Allergen-Induced Airway Narrowing In Vitro and In Vivo.
van den Berg MPM; Kurhade SH; Maarsingh H; Erceg S; Hulsbeek IR; Boekema PH; Kistemaker LEM; van Faassen M; Kema IP; Elsinga PH; Dömling A; Meurs H; Gosens R
J Pharmacol Exp Ther; 2020 Jul; 374(1):62-73. PubMed ID: 32269169
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
[TBL] [Abstract][Full Text] [Related]
29. Effect of NO-synthase and arginase inhibition in airway hyperreactivity.
Strapkova A; Antosova M; Nosalova G
Bratisl Lek Listy; 2008; 109(5):191-7. PubMed ID: 18630800
[TBL] [Abstract][Full Text] [Related]
30. Altered nitric oxide synthase, arginase and ornithine decarboxylase activities, and polyamine synthesis in response to ischemia of the rabbit detrusor.
Kawano K; Masuda H; Yano M; Kihara K; Sugimoto A; Azuma H
J Urol; 2006 Jul; 176(1):387-93. PubMed ID: 16753448
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of arginase inhibition and inhaled L-arginine administration on airway histology in a murine model of chronic asthma.
Arıkan-Ayyıldız Z; Karaman M; Tuncel T; Kiray M; Bağrıyanık A; Yilmaz O; Uzuner N; Karaman O
Allergol Immunopathol (Madr); 2014; 42(4):316-23. PubMed ID: 23578782
[TBL] [Abstract][Full Text] [Related]
32. The Promise of Plant-Derived Substances as Inhibitors of Arginase.
Girard-Thernier C; Pham TN; Demougeot C
Mini Rev Med Chem; 2015; 15(10):798-808. PubMed ID: 25963565
[TBL] [Abstract][Full Text] [Related]
33. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
[TBL] [Abstract][Full Text] [Related]
34. Arginine in asthma and lung inflammation.
King NE; Rothenberg ME; Zimmermann N
J Nutr; 2004 Oct; 134(10 Suppl):2830S-2836S; discussion 2853S. PubMed ID: 15465795
[TBL] [Abstract][Full Text] [Related]
35. Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation.
Maarsingh H; Tio MA; Zaagsma J; Meurs H
Respir Res; 2005 Mar; 6(1):23. PubMed ID: 15748286
[TBL] [Abstract][Full Text] [Related]
36. Competition of NO synthases and arginase in the airways hyperreactivity.
Strapkova A; Antosova M
Gen Physiol Biophys; 2011 Mar; 30(1):75-83. PubMed ID: 21460415
[TBL] [Abstract][Full Text] [Related]
37. L-arginine metabolism in immune-mediated glomerulonephritis in the rat.
Ketteler M; Ikegaya N; Brees DK; Border WA; Noble NA
Am J Kidney Dis; 1996 Dec; 28(6):878-87. PubMed ID: 8957040
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
[TBL] [Abstract][Full Text] [Related]
39. Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism.
Ckless K; van der Vliet A; Janssen-Heininger Y
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):645-53. PubMed ID: 17218616
[TBL] [Abstract][Full Text] [Related]
40. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.
Iniesta V; Gómez-Nieto LC; Corraliza I
J Exp Med; 2001 Mar; 193(6):777-84. PubMed ID: 11257143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
